Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.
1d
Montgomery Advertiser on MSNAlabama still fighting HIV: 'In the South is where we have the majority of the problems':Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.
A patient told MassLive she was horrified to receive a phone call from her surgeon post-operation saying she should be tested for bloodborne pathogens.
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...
2don MSN
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results